Skip to main content
. 2019 Jun 22;25:4627–4638. doi: 10.12659/MSM.913542

Figure 5.

Figure 5

Examination for the p-PKC activity using a non-radioactive method (n=32). (A) The immunoblotting image. (B) Statistical analysis for p-PKC activity. ** P<0.01 vs. Control group, ## P<0.05 vs. SCD group. 14N (28N), 14S (28S), and 14L (28L) represent the Control group, SCD group, and SCD+LEV group at 14 days (28 days) after intragastric administration, respectively. Dose of VPA: 150 mg/kg/d.